Table 3.
Zinc concentrations at the end of phase 2 diet (d 21) by treatment.
| Treatment group | |||||
|---|---|---|---|---|---|
| 1 (NC) | 2 (ZnO3-NC) | 3 (ZnO3-2) | 4 (ZnO6-4) | 5 (ZnO6) | |
| Liver | |||||
| Min. | 29 | 36 | 104 | 194 | 312 |
| Mean | 39.2 ± 10.7a | 60.7 ± 26.7a | 347 ± 117b | 520 ± 245b,c | 729 ± 264c |
| Max. | 59 | 115 | 490 | 1117 | 1120 |
| Pancreas | |||||
| Min. | 17.9 | 19.7 | 65.8 | 117.5 | 161.8 |
| Mean | 21.4 ± 3.3a | 32.1 ± 10.8a | 136 ± 53a | 472 ± 320b | 670 ± 375b |
| Max. | 25.6 | 55.8 | 216.6 | 1144 | 1344 |
| Serum | |||||
| Min. | 0.7 | 0.5 | 0.9 | 0.8 | 1.4 |
| Mean | 0.83 ± 0.13a | 0.83 ± 0.32a | 1.44 ± 0.36a,b | 2.39 ± 0.94b | 4.81 ± 2.31c |
| Max. | 1.1 | 1.7 | 2.0 | 4.0 | 8.7 |
NC = negative control. Mean values represent mean ± SEM. Within row means with differing superscripts (a,b,c) indicate a significant difference (p ≤ 0.05).